Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 1440
Gene Symbol: CSF3
CSF3
0.300 Therapeutic disease CTD_human Astemizole in the treatment of granulocyte colony-stimulating factor-induced bone pain. 7541186 1995
Entrez Id: 1440
Gene Symbol: CSF3
CSF3
0.300 Therapeutic disease CTD_human Primary systemic chemotherapy with sequential, dose-dense epirubicin and docetaxel for inoperable, locally advanced inflammatory breast cancer: a phase II study. 16076697 2005
Entrez Id: 1440
Gene Symbol: CSF3
CSF3
0.300 Biomarker disease CTD_human Phase I and pharmacologic study of paclitaxel and cisplatin with granulocyte colony-stimulating factor: neuromuscular toxicity is dose-limiting. 7692001 1993
Entrez Id: 1440
Gene Symbol: CSF3
CSF3
0.300 Biomarker disease CTD_human Docetaxel and epirubicin supported by granulocyte colony-stimulating factor first-line in advanced breast cancer. 12926135 2003
Entrez Id: 1440
Gene Symbol: CSF3
CSF3
0.300 Biomarker disease CTD_human ERE-independent ERalpha target genes differentially expressed in human breast tumors. 16298037 2005
Entrez Id: 1440
Gene Symbol: CSF3
CSF3
0.300 Biomarker disease CTD_human Weekly cisplatin, epirubicin, and paclitaxel with granulocyte colony-stimulating factor support vs triweekly epirubicin and paclitaxel in locally advanced breast cancer: final analysis of a sicog phase III study. 17047649 2006
Entrez Id: 1440
Gene Symbol: CSF3
CSF3
0.300 Therapeutic disease CTD_human Neurobiochemical changes from Taxol/Neupogen chemotherapy for metastatic breast carcinoma corresponds with suicidal depression. 9018096 1996
Entrez Id: 1440
Gene Symbol: CSF3
CSF3
0.300 Biomarker disease CTD_human Astemizole in the treatment of granulocyte colony-stimulating factor-induced bone pain. 7541186 1995
Entrez Id: 1440
Gene Symbol: CSF3
CSF3
0.300 Biomarker disease CTD_human High-dose paclitaxel with granulocyte colony-stimulating factor in patients with advanced breast cancer refractory to anthracycline therapy: a European Cancer Center trial. 7543699 1995
Entrez Id: 1440
Gene Symbol: CSF3
CSF3
0.300 Biomarker disease CTD_human Neurobiochemical changes from Taxol/Neupogen chemotherapy for metastatic breast carcinoma corresponds with suicidal depression. 9018096 1996
Entrez Id: 1440
Gene Symbol: CSF3
CSF3
0.300 Biomarker disease CTD_human Primary systemic chemotherapy with sequential, dose-dense epirubicin and docetaxel for inoperable, locally advanced inflammatory breast cancer: a phase II study. 16076697 2005
Entrez Id: 1440
Gene Symbol: CSF3
CSF3
0.300 Therapeutic disease CTD_human Weekly cisplatin, epirubicin, and paclitaxel with granulocyte colony-stimulating factor support vs triweekly epirubicin and paclitaxel in locally advanced breast cancer: final analysis of a sicog phase III study. 17047649 2006
Entrez Id: 1440
Gene Symbol: CSF3
CSF3
0.300 Therapeutic disease CTD_human Docetaxel and epirubicin supported by granulocyte colony-stimulating factor first-line in advanced breast cancer. 12926135 2003
Entrez Id: 1440
Gene Symbol: CSF3
CSF3
0.300 Therapeutic disease CTD_human ERE-independent ERalpha target genes differentially expressed in human breast tumors. 16298037 2005
Entrez Id: 1440
Gene Symbol: CSF3
CSF3
0.300 Therapeutic disease CTD_human High-dose paclitaxel with granulocyte colony-stimulating factor in patients with advanced breast cancer refractory to anthracycline therapy: a European Cancer Center trial. 7543699 1995
Entrez Id: 1440
Gene Symbol: CSF3
CSF3
0.300 Therapeutic disease CTD_human Phase I and pharmacologic study of paclitaxel and cisplatin with granulocyte colony-stimulating factor: neuromuscular toxicity is dose-limiting. 7692001 1993